American Journal of Cardiology
Volume 104, Issue 4 , Pages 507-513 , 15 August 2009

Prevalence, Predictors, and In-Hospital Outcomes of Non-Infarct Artery Intervention During Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction (from the National Cardiovascular Data Registry)

  • Matthew A. Cavender, MD

      Affiliations

    • Department of Medicine, Duke University Medical Center, Durham, North Carolina
    • Corresponding Author InformationCorresponding author: Tel: (919) 684-8111; fax: (919) 681-6448
    • ,
  • Sarah Milford-Beland, MS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Matthew T. Roe, MD, MHS

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • Eric D. Peterson, MD, MPH

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina
    • ,
  • William S. Weintraub, MD

      Affiliations

    • Christiana Care Health System, Newark, Delaware
    • ,
  • Sunil V. Rao, MD

      Affiliations

    • Duke Clinical Research Institute, Durham, North Carolina

Received 20 February 2009 ,Revised 2 April 2009 ,Accepted 2 April 2009.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 This analysis was supported by a grant from the American College of Cardiology, Washington, DC, and the Society for Cardiac Angiography and Interventions, Washington, DC.

 This analysis was supported by the National Cardiovascular Data Registry.

 Dr. Roe was supported by research grants from Schering Plough, BMS/Sanofi-Aventis, KAI Pharmaceuticals, and DeCODE Genetics; is on the consulting/advisory boards for Schering Plough, KAI Pharmaceuticals; and is on the Speakers Bureau or has received honoraria from Schering Plough and BMS/Sanofi-Aventis.

 Dr. Peterson has received research grants from Bristol-Myers Squibb, Bristol-Myers Squibb/Sanofi Pharmaceuticals Partnership, Bristol-Myers Squibb/Merck, and Schering (additional disclosure information for Dr. Peterson is available from: http://dcri.org/research/coi.jsp).

 Dr. Rao is a Consultant for Sanofi-Aventis and member of the Speakers' Bureaus for Sanofi-Aventis, Bristol Myers Squibb, and the Medicines Company and has received research funding from Momenta Pharmaceuticals, Portola Pharmaceuticals, and Cordis.

PII: S0002-9149(09)00919-9

doi: 10.1016/j.amjcard.2009.04.016

American Journal of Cardiology
Volume 104, Issue 4 , Pages 507-513 , 15 August 2009

Article Tools

* Image Usage & Resolution